Amin E Nawar is an expert in Ophthalmology at Tanta University (Egypt). As of July 2026, ScienceLeadR ranks Amin E Nawar in the top 1% of experts in Egypt for Retinal Vein Occlusion. Amin E Nawar has authored 21 publications, the most recent in 2025, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 107 (community average: 125). How the SLR is computed.

LeadR Profile

Amin E Nawar Tanta University Egypt
107 ScienceLeadR Reputation 107
Network Map

Ophthalmology

Subspecialties: Medical Imaging - Pharmacy - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2020 - 2026

Source: PubMed

Tanta University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 21

Citations

Citations: 66 1st author: 8 Last author: 4 Unique author: 4


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Efficacy of combined topical nepafenac 0.3% with suprachoroidal injection of triamcinolone acetonide using a modified custom needle in pseudopkakic cystoid macular edema.
PMID 40604486 — eye, injections, triamcinolone, triamcinolone acetonide, macular edema, eye diseases, needles, edema
BMC Ophthalmol20250
Effectiveness of Suprachoroidal Injection of Triamcinolone Acetonide in Diabetic Macular Edema Following Pars Plana Vitrectomy Using a Modified Custom Microneedle.
PMID 39051023 — injections, triamcinolone, triamcinolone acetonide, macular edema, vitrectomy, edema, microneedle drug delivery
Clin Ophthalmol20240
Effectiveness of Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema Using a Modified Microneedle.
PMID 36438589 — injections, triamcinolone, triamcinolone acetonide, macular edema, tomography, optical coherence, edema, microneedle drug delivery
Clin Ophthalmol202215
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection.
PMID 35768859 — eye diseases, macular edema, vascular endothelial growth factor a, aftercare, intravitreal injections, ranibizumab
BMC Ophthalmol20222
Modified Microneedle for Suprachoroidal Injection of Triamcinolone Acetonide Combined with Intravitreal Injection of Ranibizumab in Branch Retinal Vein Occlusion Patients.
PMID 35469288 — injections, triamcinolone, triamcinolone acetonide, retinal vein occlusion, retinal vein, ranibizumab, intravitreal injections, retinaldehyde, veins, microneedle drug delivery
Clin Ophthalmol202216

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Early Phase 1 2
Phase 1/Phase 2 1

By status:

Not yet recruiting 2
Completed 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema CRVO Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema Following Pars Plana Vitrectomy
NCT04690608 — injections, triamcinolone, triamcinolone acetonide, pharmaceutical preparations, papilledema, syringes, retinal vein occlusion, retinal vein, macular edema, vitrectomy, retinaldehyde, veins, cannula, edema
Early Phase 1Not yet recruiting2024

LeadR Networks

Main global connection map